Want to join the conversation?
$EXPE expects to incur about $20-30MM of restructuring charges for 4Q15 and about $40-50MM in 2016 related to acquisition integrations, which includes $5MM for its estimate of accelerated stock-based compensation for each period. During 3Q15, $EXPE recognized $72MM in restructuring and related reorganization charges.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)